Related references
Note: Only part of the references are listed.MGD011, A CD19 x CD3 Dual-Affinity Retargeting Bi-specific Molecule Incorporating Extended Circulating Half-life for the Treatment of B-Cell Malignancies
Liqin Liu et al.
CLINICAL CANCER RESEARCH (2017)
Vaccination with LAG-3Ig (IMP321) and Peptides Induces Specific CD4 and CD8 T-Cell Responses in Metastatic Melanoma Patients-Report of a Phase I/IIa Clinical Trial
Amandine Legat et al.
CLINICAL CANCER RESEARCH (2016)
Coinhibitory Pathways in Immunotherapy for Cancer
Susanne H. Baumeister et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 34 (2016)
Reversing T-cell Dysfunction and Exhaustion in Cancer
Hassane M. Zarour
CLINICAL CANCER RESEARCH (2016)
Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
Ana C. Anderson et al.
IMMUNITY (2016)
Nivolumab Monotherapy for First-Line Treatment of Advanced Non-Small-Cell Lung Cancer
Scott Gettinger et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Molecular Profile of Tumor-Specific CD8+ T Cell Hypofunction in a Transplantable Murine Cancer Model
Katherine A. Waugh et al.
JOURNAL OF IMMUNOLOGY (2016)
Pathological α-synuclein transmission initiated by binding lymphocyte-activation gene 3
Xiaobo Mao et al.
SCIENCE (2016)
Tr1-Like T Cells - An Enigmatic Regulatory T Cell Lineage
Anna Malgorzata White et al.
FRONTIERS IN IMMUNOLOGY (2016)
Poxvirus-Based Active Immunotherapy with PD-1 and LAG-3 Dual Immune Checkpoint Inhibition Overcomes Compensatory Immune Regulation, Yielding Complete Tumor Regression in Mice
Susan P. Foy et al.
PLOS ONE (2016)
Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T-Cells, Which Dampen CD8+ T-cell Antitumor Reactivity
Marco Donia et al.
CANCER RESEARCH (2015)
Differential Expression of Immune-Regulatory Genes Associated with PD-L1 Display in Melanoma: Implications for PD-1 Pathway Blockade
Janis M. Taube et al.
CLINICAL CANCER RESEARCH (2015)
Inhibitory receptors as targets for cancer immunotherapy
Meghan E. Turnis et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2015)
Soluble T Cell Immunoglobulin Mucin Domain 3 Is Shed from CD8+ T Cells by the Sheddase ADAM10, Is Increased in Plasma during Untreated HIV Infection, and Correlates with HIV Disease Progression
Kiera L. Clayton et al.
JOURNAL OF VIROLOGY (2015)
Nivolumab and Ipilimumab versus Ipilimumab in Untreated Melanoma
Michael A. Postow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Elevated expression of LAG-3, but not PD-1, is associated with impaired iNKT cytokine production during chronic HIV-1 infection and treatment
Jennifer A. Juno et al.
RETROVIROLOGY (2015)
LAG3 and PD1 co-inhibitory molecules collaborate to limit CD8+ T cell signaling and dampen antitumor immunity in a murine ovarian cancer model
Ruea-Yea Huang et al.
ONCOTARGET (2015)
Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells
Theodore Kouo et al.
CANCER IMMUNOLOGY RESEARCH (2015)
Combined immune checkpoint protein blockade and low dose whole body irradiation as immunotherapy for myeloma
Weiqing Jing et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
The Vigorous Immune Microenvironment of Microsatellite Instable Colon Cancer Is Balanced by Multiple Counter-Inhibitory Checkpoints
Nicolas J. Llosa et al.
CANCER DISCOVERY (2015)
LSECtin Expressed on Melanoma Cells Promotes Tumor Progression by Inhibiting Antitumor T-cell Responses
Feng Xu et al.
CANCER RESEARCH (2014)
Trafficking of LAG-3 to the Surface on Activated T Cells via Its Cytoplasmic Domain and Protein Kinase C Signaling
Joonbeom Bae et al.
JOURNAL OF IMMUNOLOGY (2014)
Alternative Activation of Human Plasmacytoid DCs In Vitro and in Melanoma Lesions: Involvement of LAG-3
Chiara Camisaschi et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2014)
MART-1 peptide vaccination plus IMP321 (LAG-3Ig fusion protein) in patients receiving autologous PBMCs after lymphodepletion: results of a Phase I trial
Emanuela Romano et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Highly prevalent colorectal cancer-infiltrating LAP+ Foxp3- T cells exhibit more potent immunosuppressive activity than Foxp3+ regulatory T cells
M. Scurr et al.
MUCOSAL IMMUNOLOGY (2014)
The effect of immune microenvironment on the progression and prognosis of colorectal cancer
Jinxiang Chen et al.
MEDICAL ONCOLOGY (2014)
Mammalian cell display for the discovery and optimization of antibody therapeutics
Peter M. Bowers et al.
METHODS (2014)
Lymphocyte Activation Gene-3 (LAG-3) Negatively Regulates Environmentally-Induced Autoimmunity
Vibha Jha et al.
PLOS ONE (2014)
Lymphocyte Activation Gene 3 (LAG-3) Modulates the Ability of CD4 T- cells to Be Suppressed In Vivo
Nicholas M. Durham et al.
PLOS ONE (2014)
Intratumoral regulatory T cells upregulate immunosuppressive molecules in head and neck cancer patients
H-B Jie et al.
BRITISH JOURNAL OF CANCER (2013)
Expression of LAG-3 is coincident with the impaired effector function of HBV-specific CD8+ T cell in HCC patients
Fu-Jun Li et al.
IMMUNOLOGY LETTERS (2013)
A phase I study of IMP321 and gemcitabine as the front-line therapy in patients with advanced pancreatic adenocarcinoma
Andrea Wang-Gillam et al.
INVESTIGATIONAL NEW DRUGS (2013)
Restoring Immune Function of Tumor-Specific CD4+ T Cells during Recurrence of Melanoma
Stephen R. Goding et al.
JOURNAL OF IMMUNOLOGY (2013)
Coexpression of CD49b and LAG-3 identifies human and mouse T regulatory type 1 cells
Nicola Gagliani et al.
NATURE MEDICINE (2013)
Immune Inhibitory Molecules LAG-3 and PD-1 Synergistically Regulate T-cell Function to Promote Tumoral Immune Escape
Seng-Ryong Woo et al.
CANCER RESEARCH (2012)
Modulation of Redox Balance Leaves Murine Diabetogenic TH1 T Cells LAG-3-ing Behind
Meghan M. Delmastro et al.
DIABETES (2012)
Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer
Julie R. Brahmer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Safety, Activity, and Immune Correlates of Anti-PD-1 Antibody in Cancer
Suzanne L. Topalian et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Exhaustion of tumor-specific CD8+ T cells in metastases from melanoma patients
Lukas Baitsch et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
MHC Class II Engagement by Its Ligand LAG-3 (CD223) Contributes to Melanoma Resistance to Apoptosis
Patrice Hemon et al.
JOURNAL OF IMMUNOLOGY (2011)
Cutting Edge: Accelerated Autoimmune Diabetes in the Absence of LAG-3
Maria Bettini et al.
JOURNAL OF IMMUNOLOGY (2011)
Using gene co-expression network analysis to predict biomarkers for chronic lymphocytic leukemia
Jie Zhang et al.
BMC BIOINFORMATICS (2010)
Differential subcellular localization of the regulatory T-cell protein LAG-3 and the coreceptor CD4
Seng-Ryong Woo et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
On the role of the inhibitory receptor LAG-3 in acute and chronic LCMV infection
Kirsten Richter et al.
INTERNATIONAL IMMUNOLOGY (2010)
LAG-3 Expression Defines a Subset of CD4+CD25highFoxp3+ Regulatory T Cells That Are Expanded at Tumor Sites
Chiara Camisaschi et al.
JOURNAL OF IMMUNOLOGY (2010)
High Expression of Lymphocyte-Activation Gene 3 (LAG3) in Chronic Lymphocytic Leukemia Cells Is Associated with Unmutated lmmunoglobulin Variable Heavy Chain Region (IGHV) Gene and Reduced Treatment-Free Survival
Jana Kotaskova et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Tumor-infiltrating NY-ESO-1-specific CD8+ T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancer
Junko Matsuzaki et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Redefining Chronic Viral Infection
Herbert W. Virgin et al.
CELL (2009)
A Phase I Pharmacokinetic and Biological Correlative Study of IMP321, a Novel MHC Class II Agonist, in Patients with Advanced Renal Cell Carcinoma
Chrystelle Brignone et al.
CLINICAL CANCER RESEARCH (2009)
Functionally Distinct LAG-3 and PD-1 Subsets on Activated and Chronically Stimulated CD8 T Cells
Joseph F. Grosso et al.
JOURNAL OF IMMUNOLOGY (2009)
LAG-3 Regulates Plasmacytoid Dendritic Cell Homeostasis
Creg J. Workman et al.
JOURNAL OF IMMUNOLOGY (2009)
Coregulation of CD8+ T cell exhaustion by multiple inhibitory receptors during chronic viral infection
Shawn D. Blackburn et al.
NATURE IMMUNOLOGY (2009)
Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II
Bitao Liang et al.
JOURNAL OF IMMUNOLOGY (2008)
LAG-3 regulates CD8+T cell accumulation and effector function in murine self- and tumor-tolerance systems
Joseph F. Grosso et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Molecular signature of CD8+ T cell exhaustion during chronic viral infection
E. John Wherry et al.
IMMUNITY (2007)
A soluble form of lymphocyte activation gene-3 (IMP321) induces activation of a large range of human effector cytotoxic cells
Chrystelle Brignone et al.
JOURNAL OF IMMUNOLOGY (2007)
CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers
Bo Huang et al.
CANCER LETTERS (2007)
Mouse TCRαβ+CD8αα intraepithelial lymphocytes express genes that down-regulate their antigen reactivity and suppress immune responses
Timothy L. Denning et al.
JOURNAL OF IMMUNOLOGY (2007)
Proliferation of activated CD1d-restricted NKT cells is down-modulated by lymphocyte activation gene-3 signaling via cell cycle arrest in S phase
Hyun-Jung Byun et al.
CELL BIOLOGY INTERNATIONAL (2007)
Metalloproteases regulate T-cell proliferation and effector function via LAG-3
Nianyu Li et al.
EMBO JOURNAL (2007)
A soluble lymphocyte activation gene-3 (sLAG-3) protein as a prognostic factor in human breast cancer expressing estrogen or progesterone receptors
F Triebel et al.
CANCER LETTERS (2006)
Galectin-3:: An open-ended story
J Dumic et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2006)
Expression of lymphocyte activation gene 3 (LAG-3) on B cells is induced by T cells
M Kisielow et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2005)
The negative regulatory function of the lymphocyte-activation gene-3 co-receptor (CD223) on human T cells
L Maçon-Lemaître et al.
IMMUNOLOGY (2005)
LAG-3 (CD223) reduces macrophage and dendritic cell differentiation from monocyte precursors
S Buisson et al.
IMMUNOLOGY (2005)
Negative regulation of T cell homeostasisby lymphocyte activation gene-3 (CD223)
CJ Workman et al.
JOURNAL OF IMMUNOLOGY (2005)
Characterization of a novel C-type lectin-like gene, LSECtin - Demonstration of carbohydrate node
WL Liu et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival
TJ Curiel et al.
NATURE MEDICINE (2004)
SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation
JM Chemnitz et al.
JOURNAL OF IMMUNOLOGY (2004)
Biochemical analysis of the regulatory T cell protein lymphocyte activation gene-3 (LAG-3; CD223)
NY Li et al.
JOURNAL OF IMMUNOLOGY (2004)
Plasmacytoid dendritic cells in immunity
M Colonna et al.
NATURE IMMUNOLOGY (2004)
Lymphocyte activation gene-3 (CD223) regulates the size of the expanding T cell population following antigen activation in vivo
CJ Workman et al.
JOURNAL OF IMMUNOLOGY (2004)
The CD4-related molecule, LAG-3 (CD223), regulates the expansion of activated T cells
CJ Workman et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
MHC class II engagement by its ligand LAG-3 (CD223) leads to a distinct pattern of chemokine and chemokine receptor expression by human dendritic cells
S Buisson et al.
VACCINE (2003)
Cutting edge: Molecular analysis of the negative regulatory function of lymphocyte activation gene-3
CJ Workman et al.
JOURNAL OF IMMUNOLOGY (2002)
Maturation and activation of dendritic cells induced by lymphocyte activation gene-3 (CD223)
S Andreae et al.
JOURNAL OF IMMUNOLOGY (2002)
Crystal structure of the human CD4 N-terminal two-domain fragment complexed to a class II MHC molecule
JH Wang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Attributes of γδ intraepithelial lymphocytes as suggested by their transcriptional profile
AM Fahrer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)